Keyphrases
Doxorubicin
100%
HCT116 Cells
100%
MiR-140
100%
Programmed Death-ligand 1 Expression
100%
MDA-MB-231 Cells
100%
Programmed Death-ligand 1 (PD-L1)
69%
Colorectal Cancer
23%
MicroRNA-34a (miR-34a)
23%
RNA Interference
15%
Breast Cancer Cells
15%
MDA-MB-231
15%
HCT116
15%
3′-untranslated Region (3′-UTR)
15%
Quantitative PCR
7%
Cancer Cells
7%
MicroRNA
7%
Cell Surface
7%
Expression Level
7%
Cancer Types
7%
Flow Cytometry
7%
Western Blot Analysis
7%
Immunofluorescence
7%
Chemotherapy Drugs
7%
Vector System
7%
Distinct Responses
7%
Reporter Vector
7%
Chemoresistance
7%
Resistance to Chemotherapy
7%
Challenging Problems
7%
Doxorubicin Treatments
7%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Programmed Death 1 Ligand 1
100%
Colorectal Cancer
21%
Malignant Neoplasm
14%
microRNA 34a
14%
Breast Cancer
14%
Flow Cytometry
7%
Chemotherapy
7%
Western Blot
7%
microRNA
7%
Drug Resistance
7%
Neuroscience
Doxorubicin
100%
Programmed Death 1 Ligand 1
100%
microRNA 34a
14%
MicroRNA
7%
Flow Cytometry
7%
Western Blot
7%
Immunofluorescence
7%
Drug Resistance
7%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Cancer Cell
21%
RNA Interference
14%
MicroRNA
7%
Flow Cytometry
7%
Immunofluorescence
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Surface Property
7%
Drug Resistance
7%
Western Blot
7%
Immunology and Microbiology
Programmed Death 1 Ligand 1
100%
Cancer Cell
21%
RNA Interference
14%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Drug Resistance
7%
Western Blot
7%
Cell Surface
7%
Immunofluorescence
7%